opportunities to learn, engage, and connect for future collaboration.Dr. Soraphol Tulayasathien, Senior Executive Vice President, Corporate Strategy Division of the SET, stated that the third year of the

as he stated. Furthermore, in early August 2021, Dr. Boon still confirmed that the vaccines would be import within August 2021 but later he admitted that such vaccines could not be imported as he

the shareholding proportion of Mr. Khanist that was not current. Accordingly, NEX disclosed information by concealing the facts that should be stated regarding the proportion of NEX's shares held

Mr. Khanist Srivajiraprabha An offence of Nex Point Public Company Limited ("NEX") for disclosing information by concealing material facts that should be stated, in accordance with Section

2022. However, on March 31, 2023, ALL submitted the form 56-1 One Report for the year 2022 without disclosing information about these disputes. Instead, it stated that “The company has no legal disputes

One Report for the year 2022 without disclosing information about these disputes. Instead, it stated that “The company has no legal disputes that may cause damage to the group’s assets exceeding five

. Sakesan Baisak (5) Mr. Suriyan Thongpikul and (6) Colonel Kanayos Suksanguan failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of The

. Sakesan Baisak (5) Mr. Yosapong Pothasuthon and (6) Colonel Kanayos Suksanguan failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of

. Sakesan Baisak (5) Mr. Yosapong Pothasuthon and (6) Mr. Suriyan Thongpikul failed to provide explanation to questions stated in SEC letter, in which, the SEC exercised the power under Section 58(2) of The

stated otherwise) 1Q19 4Q18 1Q18 1Q19 YoY LTM 1Q19 LTM 1Q18 LTM YoY Production Volume (kt) 2,966 2,818 2,325 28% 11,060 9,240 20% Consolidated Revenue1,2 3,030 2,788 2,414 26% 11,357 8,811 29% Core